Latest Breaking News On - European union medical device regulation - Page 4 : comparemela.com

Welldoc Announces CE Mark Certification

Welldoc Announces CE Mark Certification
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Kevin mcraithEuropean union medical device regulation

Why Shockwave Medical Stands Out In The Medical Device Sector (NASDAQ:SWAV)

Why Shockwave Medical Stands Out In The Medical Device Sector (NASDAQ:SWAV)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesSanta claraShockwave medical incEuropean union medical device regulationTranscatheter aortic valve replacementVascular diseaseInvestor presentation februaryShockwave javelinEarnings callEuropean unionMedical device regulationShockwave medicalSeeking alpha

CooperCompanies Announces First Quarter 2024 Results

SAN RAMON, Calif., Feb. 29, 2024 CooperCompanies , a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2024. Revenue.

United statesKim duncanCoopercompanies cooperAsia pacificAl whiteExchange commissionCompany annual report on formEuropean union medical device regulationQuarter coopervisionQuarter coopersurgicalMonths ended januaryEuropean medical devices regulationSightglass visionSan ramonPrivate securities litigation reform actCalifornia consumer privacy act

iRhythm Technologies, Inc (NASDAQ:IRTC) Q4 2023 Earnings Call Transcript

iRhythm Technologies, Inc. misses on earnings expectations. Reported EPS is $-1.26 EPS, expectations were $-0.6. iRhythm Technologies, Inc.

San franciscoUnited statesMarie thibaultAllen gongDan wilsonMargaret kaczorStephanie zhadkevichWilliam blairBrice bobzienDavid saxonQuentin blackfordScripps research translational instituteGlobal business services centerAmerican heart associationIrhythm technologies incDuke clinical research institute

Enovis Announces Fourth Quarter and Full Year 2023 Results

Continued strong momentum with fourth-quarter sales growth of 11%, organic growth of 8% Reported fourth-quarter net income from continuing operations of $0.05 per share with adjusted earnings per.

United statesKyle roseMatt trerotolaYork stock exchangeEuropean unionNew york stock exchangeEuropean union medical device regulationExchange commissionEnovis corporationFiscal yearChief executive officerSecurities litigation reform actAnnual reportQuarterly reportsConsolidated statementsNet income